First published in The Lancet on 2010 Jun.
Lancet. 2010 Jun 26;375(9733):2196-8. doi: 10.1016/S0140-6736(10)60749-0.
Authors: Hanefeld M, Forst T
Abstract
Comment on
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. [Lancet. 2010]
REACHING OUT IS EASY AND FAST – LET’S TALK
Prof. Dr. Thomas Forst
Chairman of the Executive Board
located at CRS Mannheim
LET’S TALK SCIENCE
Dr. Marc Hetzel
VP & Head of Business Development
located at CRS Management
LET’S TALK BUSINESS